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Abstract
The CD8+ T cell response to infection is characterized by the appearance of short-lived (CD127low
killer cell lectin-like receptor G 1–high) and memory-precursor (CD127high killer cell lectin-like
receptor G 1–low) effector cells. How and when central-memory T (TCM; CD62Lhigh CCR7+) cell
and effector-memory T(TEM; CD62Llow CCR7−) cell subsets are established remains unclear. We
now show that the TCM cell lineage represents an early developmental branchpoint during the
CD8+ T cell response to infection. Central-memory CD8+ T cells could be identified prior to the
peak of the CD8+ T cell response and were enriched in lymphoid organs. Moreover, the kinetics
and magnitude of TCM cell development were dependent on the infectious agent. Furthermore, the
extent of early Ag availability, which regulated programmed death-1 and CD25 expression levels,
controlled the TCM/TEM cell lineage decision ultimately through IL-2 and IL-15 signaling levels.
These observations identify key early signals that help establish the TCM/TEM cell dichotomy and
provide the means to manipulate memory lineage choices.
In recent years, much has been elucidated regarding how CD8+ T cell responses unfold.
Postinfection, extremely rare naive Ag-specific CD8+ T cells (1–3) encounter an APC
undergoing an exquisitely orchestrated and somewhat prolonged activation phase (4).
Following their activation, Ag-specific CD8+ T cells undergo a rapid expansion, after which
only ∼5–10% of the pathogen-specific CD8+ T cells are maintained as a memory
population. The resulting memory population generally contains increased numbers of Ag-
specific CD8+ T cells, compared with the naive pool. These cells exhibit altered homing
patterns, increased TCR avidity, and enhanced cytokine production, all of which enable
them to respond with increased vigor and potency to future encounters with the same
pathogen (5–8).
Questions remain about how, when, and where the decision is made for activated CD8+ T
cells to develop into memory cells. A recent study demonstrated that all effector and
memory cell populations generated following Listeria monocytogenes infection could be
generated from a single naive Ag-specific CD8+ T cell (9). Intriguingly, it has been
elegantly demonstrated that asymmetric cell division as early as the first cell division can
result in proximal and distal daughter CD8+ T cells that have different lineage fates (10).
These, and other studies (11), clearly indicate that CD8+ T cells with memory potential are
found in the effector CTL pool. Indeed, at the peak of the CD8+ T cell response a small
subset of effector cells retain CD127 (IL-7Rα) expression, and these cells go on to form the
long-lived memory pool (12,13). Further analyses have demonstrated that the effector CD8+
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T cell population contains both a small population of memory-precursor effector cells
(MPECs) and a larger number of terminally differentiated short-lived effector cells (SLECs),
distinguished on the basis of CD127 and killer cell lectin-like receptor G1 (KLRG1)
expression (14,15).
Additional layers of complexity exist within the memory CD8+ T cell population with
respect to phenotype, function, and anatomic location. For example, memory CD8+ T cells
are heterogeneous with respect to homing molecule expression and contain at least two
distinct populations: CD62Lhigh CCR7+ central-memory T (TCM) cells and CD62Llow
CCR7− effector-memory T (TEM) cells (16,17). TCM cells are predominantly found within
secondary lymphoid organs, as well as the blood and spleen. In contrast, TEM cells are
primarily found within peripheral tissues (i.e., lung, gut, and liver), as well as the blood and
spleen (18,19). It is thought that the TEM cell population provides immediate protection at
environmental barriers, whereas the TCM cell population provides a second layer of
protection upon Ag rechallenge (20). Which memory subset plays a role in mounting a
secondary response is dependent, in part, on the location of Ag challenge and characteristics
of the pathogen (21–24). Thus, understanding the salient features of memory T cell subsets
requires consideration of the parameters of each type of infection or immunization route.
It has been known for some time that CD8+ memory T cell populations gradually shift from
being largely CD62Llow to primarily CD62Lhigh (25). Two competing hypotheses have been
proposed to explain this phenomenon. In the first model, the TEM cell population is largely
transient in nature and gives rise to the TCM cell population (21,26); thus far, this effect
appears to be the result of abnormally high precursor frequencies used in adoptive transfer
systems (1,21,27–29). In the opposing model, the TEM and TCM cell pools, at least based on
CD62L expression, are independent lineages with transition of the memory population over
time to a predominantly TCM cell phenotype due to the higher homeostatic proliferative rate
of TCM cells (1,27). Although previous studies have identified memory precursors present at
the peak of the response, the precise origin of the TEM and TCM cell subsets has yet to be
elucidated. In this paper, we examined early effector cell (EEC) differentiation events after
L. monocytogenes and vesicular stomatitis virus (VSV) infection. These studies identify the
early origin of the TCM cell population and elucidate the signals required for the
development of this subset. These findings appreciably enhance our knowledge regarding
the temporal and physical interactions regulating memory CD8+ T cell generation.
Materials and Methods
Mice
Female C57BL/6 and B6-Ly5.2 mice between 5 and 8 wk old were purchased from the
National Cancer Institute. Female B6.129S4-Il2ratm1Dw/J (CD25−/−) mice were purchased
from The Jackson Laboratory (Bar Harbor, ME) or were a kind gift from Dr. Charles Surh
(Scripps Institute). C57BL/6 IL-15−/− mice (30) were bred in the University of Connecticut
Health Center animal facility. All animal protocols were approved by the University of
Connecticut Health Center Animal Care Committee.
Generation of bone marrow chimeras
Bone marrow cells were obtained from femurs and tibias of B6.129S4-Il2ratm1Dw/J and
B6-Ly5.2 mice. Recipient mice were irradiated with ∼1000 rads and subsequently injected
i.v. with 106 bone marrow cells (2:1 ratio of CD25−/−/B6). Chimeras were rested 6–8 wk
before use in experiments.
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Pathogens and infections
Both the rVSV expressing OVA (31) and recombinant L. monocytogenes expressing OVA
(32) have been previously described. Mice were infected i.v. with either 105 PFUs of VSV-
OVA or 103 CFUs of L. monocytogenes-OVA (LM-OVA).
Tissue sample preparation and flow cytometric analysis
Single-cell suspensions were prepared by collagenase digestion, as previously described
(18). The H-2Kb tetramer containing either the OVA-derived peptide SIINFEKL or VSV
nucleoprotein (VSV-N)-derived peptide RGYVYQGL was generated as previously
described (33). Analysis of the Ag-specific CD8+ T cells early postinfection by tetramer
enrichment has already been described (1). For general staining, 107 lymphocytes per
milliliter were incubated with the appropriate peptide: MHC class I tetramers, anti-CD8a
(53-6.7; BioLegend, San Diego, CA), and Fc block (2.4G2; BD Pharmingen, San Diego,
CA) for 1 h at room temperature. Cells were then washed and stained with anti-CD62L
(MEL-14; eBioscience, San Diego, CA), anti-KLRG1 (2F1; Abcam, Cambridge, U.K.),
anti-CD127 (A7R34; eBioscience), anti-CD44 (IM7; BioLegend), anti-CD25 (PC-61;
BioLegend), anti-PD1 (RPM1-30; BioLegend), and anti-CD11a (2D7; BD Biosciences, San
Jose, CA) for 30 min at 4°C. Samples were analyzed on an LSR-II (BD Biosciences), and
data analysis was accomplished using FlowJo (Tree Star, Ashland, OR).
Measurement of BrdU incorporation
BrdU was administered to infected mice in their drinking water (0.8 mg/ml). Spleen cells
were then cell surface stained as above with SIINFEKL/Kb tetramer, anti-CD8a, anti-
CD62L, and anti-CD11a. After this, cells were stained with anti-BrdU according to the
BrdU flow kit protocol (BD Biosciences).
Ab blockade of SIINFEKL/Kb
The mAb specific for the OVA derived SIINFEKL peptide presented in the context of
H-2Kb (25-D1.16) has been previously described (34). The 25-D1.16 mAb and an isotype-
matched irrelevant control Ab (MOPC-21) were purchased from the National Cell Culture
Center, and mice were injected i.p. with graded amounts of the 25-D1.16 or control mAb at
the indicated times. CD62L expression was quantified at day 7 or day 42 postinfection by
flow cytometry, as described above.
Statistical analysis
Statistical significance was determined by either a Student t test or ANOVA, using Prism 5
(Graphpad Software). Significance was set at p < 0.05.
Results
Kinetics of population conversion toward TCM cells is dependent on infection type
Both VSV and L. monocytogenes have been proposed as vaccine vectors, and secondary
responses against these pathogens are mediated by distinct memory subsets (23). Given this,
we examined CD62L expression after VSV or L. monocytogenes infection. At the peak of
the CD8+ T cell response, only a few CD62Lhigh cells were detectable in the spleen (Fig.
1A). Over time, CD62Lhigh cells steadily increased within the OVA/Kb-specific CD8+ T cell
population (Fig. 1A). Interestingly, OVA/Kb-specific CD8+ T cells induced by L.
monocytogenes infection had a significantly higher proportion of CD62Lhigh cells when
compared with VSV infection at early memory time points. However, by ∼125 d
postinfection, the frequency of CD62Lhigh cells was similar for both VSV and L.
monocytogenes infections in the spleen. When the lungs were examined, a similar trend was
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observed, although the transition toward CD62Lhigh cells occurred more slowly (Fig. 1A).
Within the lymph nodes, emergence of the CD62Lhigh population was rapid. By day 21
postinfection, most L. monocytogenes-specific cells were CD62Lhigh, whereas a proportion
(∼25%) of VSV-specific cells lacked CD62L (Fig. 1A). Thus, L. monocytogenes infection,
compared with VSV infection, drove more rapid generation of CD62Lhigh central memory
cells.
Previous work has indicated that the memory CD8+ T cell population transitions from a
CD62Llow to CD62Lhigh phenotype over time (25). This phenomenon is due to the increased
turnover rate of the CD62Lhigh relative to the CD62Llow memory cells (1,21,27). As we
have just shown, the kinetics of the transition of the memory population from CD62Llow to
CD62Lhigh differed following VSV and L. monocytogenes infection. To determine the
mechanism underlying this dichotomy, we compared memory subset proliferation after each
infection. VSV-OVA or LM-OVA memory mice were treated with BrdU in their drinking
water for 4 wk, and BrdU incorporation into the CD62Lhigh and CD62Llow OVA/Kb-
specific CD8+ T cells was quantified. Following either infection, ∼40% of the CD62Lhigh
memory CD8+ T cells had incorporated BrdU (Fig. 1B) and, in both cases, CD62Llow
memory cells incorporated less BrdU than did CD62Lhigh cells. However, a significantly
greater fraction of the CD62Llow cells in VSV-primed mice incorporated BrdU, compared
with the same subset in L. monocytogenes-infected mice (∼28% versus ∼15%; p < 0.01). A
greater ratio of CD62Lhigh memory cells incorporating BrdU was observed following L.
monocytogenes infection versus VSV infection (Fig. 1B), which likely accounts for the
delayed transition to a CD62Lhigh memory population following VSV infection.
Furthermore, enhanced proliferation of the VSV-specific TEM cell population is likely due
to the presence of low-level persistent Ag after VSV infection (35).
TCM cells originate in the memory precursor effector cell population early postinfection
The origin of the CD62Lhigh memory CD8+ T cell population remains controversial.
Originally, it was postulated that CD62Llow cells were capable of re-expressing CD62L,
resulting in the gradual generation of the CD62Lhigh memory population (21,26). However,
other studies suggest that the CD62Lhigh and CD62Llow memory populations are distinct
lineages that are not capable of interconverting (1,27). As just discussed, the conversion at
the population level of the memory pool toward increased CD62L expression is likely the
result of differences in turnover rates between the subsets (1,21,27). Because the effector
CD8+ T cell population can be subdivided into SLEC and MPEC populations, which are
CD127low KLRG1high and CD127high KLRG1low, respectively (14,15), we hypothesized
that a proportion of the MPEC population might retain expression of CD62L early
postinfection. To test this hypothesis, CD62L expression was quantified on each of the
detectable effector cell populations after VSV or L. monocytogenes infection. On day 7
postinfection, the MPEC population in the spleen and lymph nodes contained a readily
identifiable population of CD62Lhigh cells (Fig. 2A). In contrast, both the SLEC and EEC,
which is CD127low KLRG1low in phenotype, populations of OVA/Kb-specific CD8+ T cells
in the spleen, lymph nodes, or lungs largely lacked CD62L expression (Fig. 2A). The EEC
population from the lymph nodes did contain a small population of CD62Lhigh cells, but
these were extremely few in numbers and may represent cells in transition to the MPEC
population. Notably, a greater proportion of the MPECs present after L. monocytogenes
infection retained CD62L expression (Fig. 2A). In addition, CD62L expression levels of
OVA/Kb-specific CD8+ T cells were tissue specific. Few CD62Lhigh CD8+ T cells could be
detected in the lung parenchyma, but a much higher frequency of CD62Lhigh CD8+ T cells
was observed in the lymph nodes (Fig. 2A).
When the kinetics of CD62Lhigh MPEC development in the spleen was examined over time,
an interesting pattern emerged. On day 5 postinfection, the frequency of CD62Lhigh cells
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was similar between VSV- and L. monocytogenes-infected mice (Fig. 2B). Over the next 5
d, the proportion of CD62Lhigh cells declined following both infections, but declined
significantly less in mice infected with L. monocytogenes (Fig. 2B). Over the next ∼4 mo,
CD62Lhigh cells increased in the MPEC population at a much greater rate with L.
monocytogenes infection than with VSV infection, likely as a result of two factors: 1) an
early increase in the frequency of CD62Lhigh cells within the MPEC population that is then
maintained (Fig. 2A) and 2) the proliferative differences in the TEM cell populations
described above (Fig. 1B). Overall, these results shed light on the relationship of the
development of the effector cell subsets and the emergence of the CD62Lhigh memory
population.
Strength of signal and competition for Ag control TCM cell development
The factors that regulate the generation of the CD62Lhigh and CD62Llow memory
populations are not well defined. In vitro priming studies suggest that weak stimulation may
preferentially generate cells of a TCM cell phenotype, whereas prolonged stimulation will
generate TEM phenotype cells (36,37). In vivo, adoptive transfer of graded numbers of TCR
transgenic (Tg) CD8+ T cells suggests that increased competition leads to generation of
higher numbers of CD62Lhigh cells (21,27,29,38). However, adoptive transfer of high
numbers of TCR Tg cells results in a more rapid clearance of L. monocytogenes from the
spleen and reduced levels of inflammatory cytokines (29,39). Thus, these in vivo studies
cannot distinguish between the effects of Ag levels and the inflammatory milieu.
Therefore, we wished to probe whether the CD62Lhigh and CD62Llow populations received
similar levels of TCR stimulation. Programmed death-1 (PD-1), although functioning as a
negative regulator in most cases (40), is rapidly upregulated after TCR engagement (41) or
γc cytokine signaling (42). We had previously noted that PD-1 expression declined with
increased competition using graded numbers of OT-I TCR Tg cells (data not shown). Thus,
PD-1 expression at the peak of the CD8+ T cell response appeared to be tunable to the
overall strength of stimulation received by the responding cells, which is the sum of TCR,
costimulatory, and cytokine signals. Because adoptive transfer of high numbers of TCR Tg
cells resulted in weaker PD-1 upregulation and those cells tended to be CD62Lhigh, we next
wanted to examine whether PD-1 expression and CD62L expression were related during
endogenous CD8+ T cell responses. To test whether this held true in the endogenous CD8+
T cell population, C57BL/6 mice were infected with either VSV-OVA or LM-OVA. At the
peak of the OVA/Kb-specific CD8+ T cell response, PD-1 expression was measured on the
CD62Lhigh and CD62Llow subsets in the lymph nodes (Fig. 3A) and spleen (data not
shown). Interestingly, PD-1 expression inversely correlated with CD62L expression. Thus,
CD62Llow MPEC expressed PD-1, whereas CD62Lhigh MPECs largely lacked PD-1. These
data suggested that theCD62Lhigh population had received a weaker overall activation
stimulus than did the CD62Llow subset.
With the previous PD-1 data in mind, we wanted to directly test the role of TCR triggering
and Ag levels on the outcome of endogenous OVA/Kb-specific CD8+ T cells without
altering the clearance of the pathogen or inflammatory environment. To achieve this, mice
were injected with either graded amounts of 25-D1.16 mAb, which is specific for the OVA-
derived SIINFEKL peptide presented in the context of H-2Kb (34), or with an isotype-
matched control Ab (MOPC-21). After injection, mice were infected with VSV-OVA, and 7
or 42 d later, OVA/Kb-specific CD8+ T cells in the spleen and lymph nodes were analyzed.
In line with the previous observation, injection of increasing amounts of 25-D1.16 mAb
resulted in a dose-dependent decrease in PD-1 expression on OVA/Kb-specific MPECs (Fig.
3B). Injection of increasing amounts of the 25-D1.16 mAb also decreased the magnitude of
the OVA/Kb-specific CD8+ T cell response (Fig. 4A). Interestingly, 25-D1.16 mAb
treatment did not affect the overall distribution of the EEC, MPEC, and SLEC subsets (data
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not shown). In contrast, CD62L expression was substantially altered by the injection of the
25-D1.16 mAb (Fig. 4A). Treatment with 250 μg of the 25-D1.16 Ab, but not 50 μg,
resulted in a significantly higher proportion of the Ag-specific MPECs expressing CD62L (p
< 0.001) (Fig. 4A). Furthermore, this difference in CD62L expression was maintained into
memory (Fig. 4C). Similar data were obtained using the 25-D1.16 mAb blockade during
LM-OVA infection (Fig. 4D). As a control, we also examined the CD8+ T cell response
against the VSV-N in the VSV-OVA infected animals and found no differences in the
magnitude of the VSV-N/Kb-specific CD8+ T cell response or in the phenotype of the
responding cells (Fig. 4B). This finding indicated that the 25-D1.16 mAb did not deplete
APC or affect “bystander” responses. Thus, competition for Ag and apparent TCR signal
strength regulated not only CD8+ T cell expansion but also TCM cell development.
The timing of naive cell entry into the response has also been proposed to regulate memory
development (43). Using adoptive transfer systems, cells added into an ongoing response
tend to preferentially form TCM-type memory cells (29,44,45). In addition, the duration of T
cell–APC interaction required to drive memory development has been a matter of
discussion. Early studies suggested that only a few hours of stimulation with cognate Ag
were needed to drive a productive response (46,47), although recent work suggests that a
more prolonged period (72–96 h) of Ag availability is required for an optimal T cell
response (4,15,48,49). With this in mind, we asked when the CD62L expression pattern was
determined. To achieve this, mice were infected with VSV-OVA and treated with 250 μg of
the 25-D1.16 mAb at various times. At 7 d postinfection, the OVA/Kb-specific CD8+ T cell
response was monitored in the spleen and lymph nodes. Interestingly, effector cell
expansion and CD62L expression were differentially regulated. Mice treated with 25-D1.16
mAb just prior to infection had a significantly reduced OVA/Kb-specific CD8+ T cell
response, with a greater proportion of the responding OVA/Kb-specific CD8+ T cells being
CD62Lhigh (Fig. 5A). Whereas 25-D1.16 mAb blockade as late as 72 h postinfection
impaired expansion, mAb-induced modulation of CD62L expression occurred only up to 48
h postinfection and was most notable when mAb was given no later than 24 h postinfection
(Fig. 5A). Similarly, during LM-OVA infection, maximal Ag availability for up to 48 h was
necessary to induce changes in CD62L regulation, whereas 96 h was needed for optimal
expansion (Fig. 5B). Using total numbers of OVA/Kb-specific CD8+ T cells, we also
calculated the TEM/TCM cell ratio among MPECs after VSV infection and 25-D1.16 mAb
treatment on different days (Fig. 5C). We observed that not only was the overall number of
MPECs inhibited by 25-D1.16 treatment early, but also the ratio of TEM/TCM phenotype
cells was again skewed toward TCM cells (Fig. 5C). The ratio in control mice was 9.6:1,
whereas treatment at day 0 or day 1 decreased the ratio to 2.8:1 and 2:1, respectively.
Treatment on days 2 or 3 altered the ratio to ∼4:1, but the effect was waning with day 4
treatment (7:1). The magnitude of the effect correlated with the extent of the overall
inhibition of the response resulting from Ag blockade. These data demonstrated that the
concentration of available Ag during the first 3 d of CD8+ T cell priming was important in
regulating CD62L expression, whereas Ag accessibility was necessary for up to 96 h for
optimal CD8+ T cell expansion, as previously suggested (4). These data indicated that the
TCM/TEM cell lineage choice is made earlier than previously described based on the
“latecomer” hypothesis (29,44,45), but does not rule out the possibility of such a
phenomenon occurring.
IL-2 and IL-15 signaling play key roles in regulating CD62L expression in vivo
In addition to TCR-mediated signals, cytokines of the γc family are also important in
memory T cell development and survival (50). Moreover, in vitro studies have demonstrated
that IL-2 and IL-15 can generate effector CD8+ T cell populations that resemble TEM and
TCM cell populations, respectively (51,52). It was therefore of interest to determine the roles
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of these cytokines in memory subset differentiation. CD25 expression by Ag-specific CD8+
T cells was maximal at day 4 postinfection (Fig. 6A). By comparison, alterations of CD62L
on the Ag-specific CD8+ T cells following 25-D1.16 mAb administration only occurred
when the mAb was administered prior to maximal CD25 expression (Figs. 4, 5). Thus, we
tested whether 25-D1.16 mAb administration could alter CD25 levels on the responding Ag-
specific CD8+ T cells. Indeed, 4 d after LM-OVA infection, Ag-specific CD8+ T cells
expressed high levels of CD25 in the control mice, but cells from mice treated with 250 μg
of 25-D1.16 had substantially lower CD25 levels (Fig. 6B). Thus, the effect of Ag
competition could be mediated downstream by cytokines of the γc family.
The receptors for both IL-2 and IL-15 share two common receptor subunits, CD122
(IL-2/15rβ) and CD132 (γc receptor), and each has unique α-chains to form the high-affinity
receptor (50). To test the in vivo role of IL-2 and IL-15 in the generation of the TCM and
TEM memory cell subsets, C57BL/6:CD25−/− mixed bone marrow chimeras, IL-15−/− mice,
and C57BL/6 mice were infected with LM-OVA. At the peak of the CD8+ T cell response
(day 9), splenic OVA/Kb-specific MPECs were analyzed for CD62L expression. At this
time, CD25−/− OVA/Kb-specific CD8+ T cells had a significantly increased frequency of
CD62Lhigh cells (p = 0.0325) (Fig. 6C), whereas in the absence of IL-15, the frequency of
CD62Lhigh cells was significantly decreased (p = 0.0179) (Fig. 6C). These data extend the
prior in vitro studies (51,52) and demonstrated that in vivo IL-2–derived signals promote the
downregulation of CD62L and formation of the TEM cell population, whereas IL-15–derived
signals promote the expression of CD62L and formation of TCM cells. Because the 25-
D1.16 blockade inhibited expression of CD25 on the responding CD8 T cells, we next asked
whether 25-D1.16 blockade of Ag presentation and CD25 expression had overlapping
functions in regulating CD62L expression. For these experiments C57BL/6:CD25−/− mixed
bone marrow chimeras were treated with 250 μg of 25-D1.16 or MOPC-21. The mice were
then infected with 103 CFU of LM-OVA, and the generation of CD62Lhigh TCM cells within
the MPEC population on day 9 was analyzed. C57BL/6:CD25−/− mixed bone marrow
chimeras treated with MOPC-21 had a low frequency of CD62Lhigh TCM cells in the
C57BL/6 compartment and an elevated frequency in the CD25−/− compartment.
Interestingly, when the C57BL/6:CD25−/− mixed bone marrow chimeras were treated with
25-D1.16, there was an enhancement of CD62Lhigh TCM cells only of C57BL/6 origin, but
not of CD25−/− origin (Fig. 6D). Taken together, these data demonstrated that CD62Lhigh
TCM cells are generated when Ag is limiting, and this occurs through the limitation of IL-2–
mediated signals.
Discussion
Because immunological memory is the foundation of vaccination, an understanding of the
factors regulating the development of the memory population is critical. Furthermore, it has
been illustrated that TCM and TEM cells have different recall and protective abilities,
depending on the challenge infection (21–24,53). Therefore, understanding the factors
governing and regulating the differentiation of the memory subsets is important for
generating better vaccines. Strikingly, we have demonstrated that CD62Lhigh CD8+ T cells
were mostly found within the MPEC population and could be identified as early as day 5
postinfection (Fig. 2). Furthermore, regulation of CD62L was tied to the overall strength of
the activation signal received by the Ag-specific CD8+ T cell early during priming (Figs. 4–
6). Our data indicate that the overall potency of the activation signal is, at least in part, the
net result of integrating pMHC-TCR engagement and γc cytokine signals.
The origin of the memory CD8+ T cell population has long been debated. A recent report
from Busch and colleagues (9) elegantly demonstrated that a single naive CD8+ T cell could
give rise to all the different subsets of effector and memory CD8+ T cells. Thus, it is critical
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to determine the mechanism(s) by which effector cells survive to form the memory
population. Furthermore, it is important to understand the relationship of the TCM/TEM cell
dichotomy within the different effector CD8+ T cell populations. Earlier work demonstrated
that a population of effector CD8+ T cells retains the expression of CD127 (IL-7Rα) (12,13).
However, IL-7 signals are not necessary for the survival of that population (54,55). Recent
work, using CD127 in combination with KLRG1 expression, has more extensively defined
the effector cell populations present during many infections, whereby memory precursor
effector cells are defined as CD127high KLRG1low and SLECs are defined as CD127low
KLRG1high (14,15,56,57). However, the relationship of the TCM/TEM cell dichotomy was
not explored. In this paper, we demonstrate that only when the MPEC population became
detectable did CD62Lhigh cells appear. Interestingly, over the next week the frequency of
CD62Lhigh OVA/Kb-specific CD8+ T cells actually decreased before slowly shifting to a
TCM cell phenotype, as previously described (25). Previous in vitro studies showed that
CD62L expression is regulated in a three-step process whereby initial downregulation is
mediated by proteolytic cleavage, followed by a rapid re-expression of CD62L and lastly a
gradual genetic modulation of CD62L expression (58,59). This three-step model supports
our in vivo observations examining the early dynamics of CD62L expression on activated
Ag-specific CD8+ T cells. 1) EECs lose cell surface expression of CD62L likely by
proteolytic cleavage after initial CD8+ T cell activation; 2) as the immune response
continues, heterogeneity within the MPEC population is generated by a small proportion of
the Ag-specific CD8+ T cells that are genetically competent to re-express CD62L; and 3) the
remainder of the MPECs, as well as EECs and SLECs, undergo epigenetic modification of
the CD62L promoter region, prohibiting further gene expression. Thus, memory cell
heterogeneity and trafficking patterns originated within the first week of infection. With
time, the TCM cell population later dominates the memory pool due to its increased turnover
rate, as previously seen (21,27). However, as shown in our work, the rate of conversion
differs between pathogens.
The identity of the precise signals that regulate CD62L expression and the differentiation of
the TCM cell population in vivo have been unclear. Competition for Ag early in the priming
of naive CD8+ T cells will alter the overall signal strength delivered to the responding CD8+
T cells. Previous studies have demonstrated that adoptive transfer of large numbers of TCR
Tg CD8+ T cells leads to the generation of more TCM cells (1,21,27,29). This effect is
thought to be due to high competition for Ag, but the adoptive transfer of high numbers of
TCR Tg CD8+ T cells can also alter the inflammatory milieu owing to rapid clearance of the
infection (29,39). Thus, we have used the 25-D1.16 (anti-SIINFEKL/Kb) mAb in a novel
manner to specifically limit SIINFEKL/Kb Ag presentation in vivo. Using this method, we
have observed two intriguing aspects of CD8+ T cell activation: expansion, and memory
differentiation. First, optimal CD8+ T cell expansion required prolonged Ag availability Our
previous finding indicates that late APC–T cell interactions form in an Ag-dependent
manner (4), and our current data now show that these events enhance T cell expansion. In
contrast, restriction of Ag availability only during the first 2–3 d postinfection altered
CD62L expression. Therefore, a kinetic dichotomy exists between the requirement for Ag
for optimal expansion and CD62L regulation.
One classic consequence of TCR-mediated signaling is the upregulation of CD25 (60). Our
data demonstrated that CD25 expression peaked between days 3 and 5 (Fig. 6A) (57,61,62),
a time just beyond when 25-D1.16 mAb administration became ineffective at modulating
CD62L expression. Indeed, restricting Ag availability limited CD25 expression on the
responding Ag-specific CD8+ T cells (Fig. 6B) and also decreased PD-1 expression (Fig.
3B). Furthermore, the observation that the strength of TCR signaling regulates CD25
expression is supported by the fact that vaccination with a weak altered-peptide ligand
resulted in diminished CD25 expression on Ag-specific CD8+ T cells (63). In addition, at
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least in vitro, high levels of inflammation generated using unmethylated CpG DNA and/or
IL-12 can enhance CD25 expression during T cell activation (64). Furthermore, limiting
inflammation during L. monocytogenes infection by treatment of mice with ampicillin
resulted in enhanced TCM cell formation, but the expression of CD25 was not explored
(65,66). Interestingly, IL-21 can limit the expression of CD25 on responding CD8+ T cells
(67) and enhances CD62L expression (67,68). These results fit well with our observation
that IL-2 signaling results in decreased CD62L expression, whereas IL-15 signaling
promotes CD62L expression in vivo. Furthermore, limiting Ag availability did not enhance
CD62L expression in CD25-deficient cells, suggesting that the regulation of CD62L is
ultimately controlled by the levels of IL-2 and IL-15 signaling.
In molecular terms, recent reports have demonstrated that the PI(3)K and mTOR signaling
networks play a critical role in regulating T cell migration through control of CD62L,
CCR7, and spingosine-1-phospate receptors (52,69). Cantrell and colleagues (52,70) have
demonstrated that IL-2 strongly activates the PI(3)K pathway, leading to mTOR activation
and the subsequent genetic silencing of CD62L, whereas IL-15 only weakly activates the
PI(3)K and mTOR axis and results in the maintenance of CD62L expression. Furthermore, a
recent report found that modulating mTOR activity by the administration of low doses of
rapamycin, an inhibitor of mTORC1, resulted in an enlarged memory population, which
more rapidly became central-memory in phenotype (71). Administration of rapamycin
appears to be working by enhancing the Eomes/T-bet ratio (72), which favors memory
differentiation (73). Skewing the Eomes/T-bet ratio toward Eomes would likely enhance
TCM cell emergence because Tbx21−/− CD8+ T cells become CD62Lhigh more rapidly (74).
Our in vivo studies using CD25−/− CD8+ T cells and IL-15−/− mice affirm previous in vitro
studies examining the ability of IL-2 and IL-15 to support the differentiation of TEM- and
TCM-like CD8+ T cell populations, respectively (51,52). In addition, a recent report similarly
found that CD25low effector CD8+ T cells preferentially became TCM cells (62). IL-2 could
be working through the Blimp1/Bcl6 axis, as Prdm1−/− CD8+ T cells acquire a CD62Lhigh
phenotype more rapidly (75), whereas Bcl6−/− CD8+ T cells have a decreased frequency of
TCM cells (76). Furthermore, high levels of IL-2 are known to enhance Blimp1 expression
while repressing Bcl6 expression in vitro (64). CD4+ T cell help is also known to result in
decreased CD62L expression on Ag-specific CD8+ T cells (77). We hypothesize that this
effect is likely due to IL-2 production by the “helping” CD4+ T cells (57,78), which will
then modulate CD62L expression. Our data demonstrated a heretofore unappreciated linkage
between Ag availability and IL-2/IL-15 cytokines in the regulation of CD62L expression.
In summary, our results demonstrated that the differentiation of effector and memory CD8+
T cell populations occurred very early in the immune response to pathogens. At these early
time points, signals generated by TCR engagement, costimulatory molecules, and the
cytokine milieu are integrated by the responding CD8+ T cells to shape the development of
effector and memory subsets. Thus, a thorough understanding of the early inflammatory
environment and the cellular sources generating this environment will play a critical role in
understanding the development of immunological memory.
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KLRG1 killer cell lectin-like receptor G 1
LM-OVA Listeria monocytogenes-OVA
MFI mean fluorescence intensity
MPEC memory-precursor effector cell
PD-1 programmed death-1
SLEC short-lived effector cell
TCM central-memory T
TEM effector-memory T
Tg transgenic
VSV vesicular stomatitis virus
VSV-N VSV nucleoprotein
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FIGURE 1.
Infection type and turnover rates of TEM cells influence population conversion to TCM cells.
A, At the indicated times postinfection of C57BL/6 mice with either VSV-OVA or LM-
OVA, the OVA/Kb-specific CD8+ T cells in the spleen, lungs, and lymph nodes were
monitored for expression of CD62L. Histograms are gated on OVA/Kb-specific CD8+ T
cells. The open histograms show CD62L expression after LM-OVA infection and the filled
histograms after VSV-OVA infection. Values in the right corner of each histogram represent
the mean percentage of CD62Lhigh cells. Each histogram is representative of four or five
mice per time-point and three independent experiments. B, At 30 d after either VSV-OVA or
LM-OVA infection, C57BL/6 mice were given BrdU in their drinking water for 4 wk, at
which time BrdU incorporation in OVA/Kb-specific CD8+ T cells in the spleen was
determined. Filled histograms show BrdU incorporation in CD62Lhigh or CD62Llow OVA/
Kb-specific CD8+ T cells, whereas open histograms (dark line) represent an isotype control
stain. The graph shows the BrdU incorporation ratio of CD62Lhigh to CD62Llow OVA/Kb-
specific memory CD8+ T cells. A value >1.0 indicates that more CD62Lhigh memory cells
have incorporated BrdU. Each bar represents the mean value of three mice ± one SD. These
data are representative of two independent experiments. Statistical significance was
determined using a Student t test. ***p < 0.05.
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FIGURE 2.
Early postinfection TCM CD8+ T cells are found in the MPEC population. A, C57BL/6 mice
were infected i.v. with either VSV-OVA or LM-OVA, and 7 d later the OVA/Kb-specific
CD8+ T cell population in the spleen, lungs, and lymph nodes was analyzed. Each effector
cell subpopulation, based on KLRG1 and CD127 expression, was assessed for CD62L cell
surface expression. The zebra plots are gated on the OVA/Kb-specific CD8+ T cells,
whereas the histograms are gated on the respective effector cell subpopulations within the
Ag-specific subset. The open histograms show CD62L expression after LM-OVA infection
and the filled histograms after VSV-OVA infection. Values in the right corner of each
histogram represent the mean percentage of CD62Lhigh cells. These data are representative
of four or five mice per group and three independent experiments. B, Expression kinetics of
CD62L after i.v. infection with either VSV-OVA or LM-OVA on the CD127high KLRG1low
(MPEC) OVA/Kb-specific CD8+ T cell population was monitored in the spleen. The graph
represents the proportion of CD127high KLRG1low OVA/Kb-specific CD8+ T cells
expressing CD62L. The data presented are the mean of four or five mice per group ± one SD
and is representative of two independent experiments.
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FIGURE 3.
PD-1 expression inversely correlates with CD62L expression of effector cell subsets and is
dependent on the strength of TCR engagement. A, C57BL/6 mice were infected i.v. with
either VSV-OVA or LM-OVA. At 7 d, expression of PD-1 on both CD62Lhigh and
CD62Llow OVA/Kb-specific CD8+ T cells was monitored in the lymph nodes. Contour plots
are representative of four or five mice per group and three independent experiments. The top
panels are gated on OVA/Kb-specific CD8+ T cells, whereas the bottom panels are further
gated on the MPEC pool (CD127high KLRG1low). Values represent the average MFI of
PD-1 staining on the CD62Lhigh and CD62Llow populations. Similar data were also obtained
from spleen cell analysis. B, C57BL/6 mice were treated i.p. with either 50 μg or 250 μg of
the 25-D1.16 Ab or 250 μg of a control Ab (MOPC-21), after which the mice were infected
i.v. with VSV-OVA. At 7 d, mice were sacrificed, and expression of PD-1 on the OVA/Kb-
specific CD8+ T cells was measured in the spleen. The bar graph is a representation of MFI
of PD-1 expression on the CD127high KLRG1low (MPEC) OVA/Kb-specific CD8+ T cells.
Data are representative of four or five mice per group and two independent experiments.
Statistical significance was determined by a one-way ANOVA analysis. ***p < 0.001; *p <
0.05. MFI, mean fluorescence intensity.
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FIGURE 4.
Ag availability during the CD8+ T cell response to infection regulates CD62L expression
within the MPEC population. C57BL/6 mice were treated i.p. with either 50 μg or 250 μg of
the 25-D1.16 Ab or 250 μg of a control Ab (MOPC-21), after which the mice were infected
i.v. with VSV-OVA (A–C) or with LM-OVA (D). At 7 d, the magnitude and phenotype of
the OVA/Kb-specific (A, D) or VSV-N/Kb-specific (B) CD8+ T cells were monitored in the
spleen. Furthermore, 42 d later, mice were sacrificed, and the magnitude and phenotype of
the OVA/Kb-specific CD8+ T cells were monitored in the spleen (C). Dot plots are gated on
CD8+ T cells. Values represent the group mean ± one SD. The bar graphs are
representations of CD62L expression on the CD127high KLRG1low (MPEC) Ag-specific
CD8+ T cells. Data are representative of five mice per group and two independent
experiments. Similar data were also observed in the lymph nodes. Statistical significance
was determined by a one-way ANOVA analysis. ***p < 0.001; **p < 0.01; *p < 0.05.
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FIGURE 5.
Ag availability early during CD8+ T cell priming regulates CD62L expression within the
MPEC population following infection. C57BL/6 mice were treated i.p. with 250 μg of either
25-D1.16 Ab at indicated times or 250 μg of the control Ab (MOPC-21) on day 0. Mice
were then infected i.v. with VSV-OVA (A, C) or LM-OVA (B), and 7 d later the OVA/Kb-
specific CD8+ T cell population was analyzed in the spleen. Dot plots are gated on CD8+ T
cells and display the size of the OVA/Kb-specific CD8+ T cell response. Values represent
the group mean ± one SD. The bar graph is a representation of CD62L expression on the
CD127high KLRG1low (MPEC) OVA/Kb-specific CD8+ T cells. C shows the ratio of
CD62L−/CD62L+ cells based on total MPEC numbers. Data are representative of five mice
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per group and two independent experiments. Similar data were also observed in the lymph
nodes. Statistical significance was determined by a one-way ANOVA analysis. ***p <
0.001; **p < 0.01; *p < 0.05.
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FIGURE 6.
Opposing action of IL-2 and IL-15 signaling on regulation of CD62L expression. A, C57BL/
6 mice were infected i.v. with 103 CFU of LM-OVA. At the indicated times, expression of
CD25 on the OVA/Kb-specific CD8+ T cells was quantified in the spleen by tetramer
staining. These data are representative of three to five mice per group and two independent
experiments. B, C57BL/6 mice were treated i.p. with 250 μg of either 25-D1.16 or a control
mAb (MOPC-21). After this, mice were infected i.v. with 103 CFU of LM-OVA. At 4 d,
expression of CD25 on the OVA/Kb-specific CD8+ T cell population in the spleen was
analyzed by tetramer enrichment. The filled gray histogram shows CD25 expression on the
bulk naive CD8+ T cell population (CD11alow CD44low). The open histograms show CD25
expression on the OVA/Kb-specific CD8+ T cells from control mice (blue line) and 25-
D1.16-treated mice (red line). These data are representative of three to five mice and four
independent experiments. C, CD25−/− mixed bone marrow chimeras, C57BL/6, and
IL-15−/− mice were infected i.v. with 103 CFU of LM-OVA. At 9 d, expression of CD62L
on the splenic CD127high KLRG1low (MPEC) OVA/Kb-specific CD8+ T cells was
quantified. Data are representative of three to five mice per group and two independent
experiments. Statistical significance was measured using a Student t test. *p < 0.05. D,
CD25−/− mixed bone marrow chimeras were treated i.p. with 250 μg of either 25-D1.16 or a
control mAb (MOPC-21). After this, mice were infected i.v. with 103 CFU of LM-OVA. At
9 d, expression of CD62L on the splenic CD127high KLRG1low (MPEC) OVA/Kb-specific
CD8+ T cells was quantified. Data are representative of three to five mice per group and two
independent experiments. Statistical significance was measured using a Student t test. **p <
0.01; *p < 0.05.
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